<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="58774">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01995734</url>
  </required_header>
  <id_info>
    <org_study_id>CSOM230CUS33</org_study_id>
    <nct_id>NCT01995734</nct_id>
  </id_info>
  <brief_title>An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly</brief_title>
  <acronym>ACCESS</acronym>
  <official_title>An ACromegaly, Open-label, Multi-CEnter, Safety Monitoring Program for Treating Patients With SOM230 (Pasireotide) LAR Who Have Need to Receive Medical Therapy (ACCESS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study is planned as an expanded treatment protocol to provide acromegalic
      patients for whom medical therapy is appropriate access to pasireotide LAR while regulatory
      approval for pasireotide is sought.
    </textblock>
  </brief_summary>
  <overall_status>Available</overall_status>
  <phase>Phase 4</phase>
  <study_type>Expanded Access</study_type>
  <study_design>N/A</study_design>
  <condition>Acromegaly</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pasireotide long acting release formulation</intervention_name>
    <description>Pasireotide LAR will be administered intramuscularly (i.m.) every 28 days until pasireotide becomes commercially available and reimbursed or until 31 December 2015, whichever occurs first.</description>
    <arm_group_label>Pasireotide long acting release formulation</arm_group_label>
    <other_name>SOM230 LAR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with confirmed diagnosis of active acromegaly with elevated IGF-1 (&gt;ULN) and
             random GH (&gt;1 μg/L) within 30 days of screening.

          -  Patients who are not controlled by pituitary surgery or who are not eligible for or
             refuse surgery.

          -  For patients on medical treatment for acromegaly the following washout periods must
             be completed before screening assessments are performed:

               -  Dopamine agonists (bromocriptine, cabergoline): 4 weeks

               -  GH-receptor antagonists (pegvisomant): 8 weeks

               -  Somatostatin analogues: no washout period required

          -  Karnofsky performance status ≥ 60.

        Exclusion Criteria:

          -  Concomitant treatment with somatostatin analogues unless concomitant treatment was
             discontinued 28 days before first pasireotide LAR injection is administrated.

          -  Concomitant treatment with growth hormone receptor (GHR)-antagonists or dopamine
             agonists unless concomitant treatment was discontinued and the washout period was
             completed before the screening assessments are performed.

          -  Patients with compression of the optic chiasm causing any visual field defect for
             whom surgical intervention is indicated.

          -  Patients who require a surgical intervention for relief of any sign or symptom
             associated with tumor compression.

          -  Patients who have undergone major surgery/surgical therapy for any cause within 4
             weeks of screening.

          -  Patients who have received radiotherapy of the pituitary within 4 weeks prior to
             screening or have not recovered from side effects of radiotherapy.

          -  Patients who have a history of hypothyroidism and who are not adequately treated with
             stable doses of thyroid hormone replacement therapy.

          -  Patients with active malignant disease within the last five years (with the exception
             of basal cell carcinoma or carcinoma in situ of the cervix).

          -  Diabetic patients whose blood glucose is poorly controlled.

        Other protocol-defined inclusion/exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Novartis Pharmaceuticals</last_name>
    <role>Study Director</role>
    <affiliation>Novartis Pharmaceuticals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Novartis Pharmaceuticals</last_name>
    <phone>1-888-669-6682</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Novartis Pharmaceuticals</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham Univ. of Alabama Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>+1 205 801 8490</phone>
    </contact>
    <investigator>
      <last_name>Tom Brooks Vaughan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Panda Medical Associates/Clin TriCo Clin TriCo</name>
      <address>
        <city>Peoria</city>
        <state>Arizona</state>
        <zip>85381</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>623-241-9028</phone>
    </contact>
    <investigator>
      <last_name>Chioma Iweha</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital Medical Center St. Joseph's Hosp Med Ctr (2)</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>602-406-6540</phone>
    </contact>
    <investigator>
      <last_name>Laura Knecht</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Diego Coastal Endocrinology Group</name>
      <address>
        <city>Chula Vista</city>
        <state>California</state>
        <zip>91911</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>619-691-0388</phone>
    </contact>
    <investigator>
      <last_name>Georges M. Argoud</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California at Los Angeles UCLA - Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>310-967-1884</phone>
    </contact>
    <investigator>
      <last_name>Anthony P. Heaney</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John Wayne Cancer Institute Saint John's Health Center</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>310-582-7457</phone>
    </contact>
    <investigator>
      <last_name>Daniel F. Kelly</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>650-721-1020</phone>
    </contact>
    <investigator>
      <last_name>Laurence Katznelson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harbor-UCLA Medical Center Center for Men's Health</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90509</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>310-222-1852</phone>
    </contact>
    <investigator>
      <last_name>Ronald Swerdloff</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>George Washington University Medical Center Medical Faculty Associates Inc</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>202-741-2764</phone>
    </contact>
    <investigator>
      <last_name>Zachary Litvak</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Diabetes &amp; Endocrine Care Dept.of Ctr for Diab&amp;Endoc - 2</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33021</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>954-963-7100</phone>
    </contact>
    <investigator>
      <last_name>Sam Lerman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Florida Endocrine &amp; Diabetes Consultants</name>
      <address>
        <city>Maitland</city>
        <state>Florida</state>
        <zip>32751</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>407-629-4901</phone>
    </contact>
    <investigator>
      <last_name>Penny S. Glickman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Endocrine Assoc of FL</name>
      <address>
        <city>Ocoee</city>
        <state>Florida</state>
        <zip>34761</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>407-331-1117</phone>
    </contact>
    <investigator>
      <last_name>Jose Mandry</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University School of Medicine/Winship Cancer Institute Emory University (5)</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>404-778-5969</phone>
    </contact>
    <investigator>
      <last_name>Adriana Ioachimescu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dr. Steven Leichter, Endocrine Consultant</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31901</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>706-322-1700</phone>
    </contact>
    <investigator>
      <last_name>Steven Leichter</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University Endo, Metabolism and Molecular</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611-3308</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>312-503-4130</phone>
    </contact>
    <investigator>
      <last_name>Mark Molitch</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John H. Stroger, Jr., Hospital of Cook County</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>312-864-0537</phone>
    </contact>
    <investigator>
      <last_name>Leon Fogelfeld</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Quincy Medical Group</name>
      <address>
        <city>Quincy</city>
        <state>Illinois</state>
        <zip>62301</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>+1 217 222 6550 ext. 6677</phone>
    </contact>
    <investigator>
      <last_name>Sharon Harris</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Johns Hopkins University School of Medicine Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>410-955-3921</phone>
    </contact>
    <investigator>
      <last_name>Roberto Salvatori</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sinai Hospital of Baltimore Sinai Hospital, Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21215</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>410-601-5961</phone>
    </contact>
    <investigator>
      <last_name>Henry G. Fein</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center Tufts Medical Ctr</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>617-636-5689</phone>
    </contact>
    <investigator>
      <last_name>Ronald M. Lechan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>314-362-8681</phone>
    </contact>
    <investigator>
      <last_name>Julie Silverstein</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Diabetes and Endocrinology Associates, PC Diabetes and Endocrine Assoc</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68131</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>310-582-7457</phone>
    </contact>
    <investigator>
      <last_name>Sarah B Konigsberg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PALM MEDICAL RESEARCH CENTER Palm Research Center, Inc</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89148</zip>
        <country>United States</country>
      </address>
    </facility>
    <investigator>
      <last_name>Samer Nakhle</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of New Mexico School of Medicine University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>505-272-4658</phone>
    </contact>
    <investigator>
      <last_name>Kathleen Colleran</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center- New York Presbyterian Neuroendocrine Unit</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>212-305-4921</phone>
    </contact>
    <investigator>
      <last_name>Pamela U. Freda</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College Weill Cornell Med. College (2)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>212-746-5620</phone>
    </contact>
    <investigator>
      <last_name>Theodore Schwartz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai School of Medicine Mt. Sinai Schoof of Med.</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>212-241-6169</phone>
    </contact>
    <investigator>
      <last_name>Eliza B. Geer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Endocrine Associates of Long Island, P.C.</name>
      <address>
        <city>Smithtown</city>
        <state>New York</state>
        <zip>11787</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>+1 631 265 5501</phone>
    </contact>
    <investigator>
      <last_name>Michael Howard Shanik</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina Chapel Hill UNC Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27514</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>919-966-1374</phone>
    </contact>
    <investigator>
      <last_name>Julie Sharpless</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Cleveland Clinic (18)</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>216-445-8538</phone>
    </contact>
    <investigator>
      <last_name>Amir Hamrahian</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toledo Clinic Toledo Clinic, Inc.</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43623</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>419-479-5560</phone>
    </contact>
    <investigator>
      <last_name>Ian Elliot</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Sciences University Oregon Health &amp; Sciences</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>503-494-0170</phone>
    </contact>
    <investigator>
      <last_name>Maria Fleseriu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Jefferson University Physician</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>215-955-1925</phone>
    </contact>
    <investigator>
      <last_name>Monika Shirodkar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania - Clinical Studies Unit Translational Research</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>215-898-0208</phone>
    </contact>
    <investigator>
      <last_name>Peter J. Snyder</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allegheny Endocrinology Associates Allegheny Endo Associates</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>412-359-6538</phone>
    </contact>
    <investigator>
      <last_name>Murray B. Gordon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital Hallett Center</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>401-444-3420</phone>
    </contact>
    <investigator>
      <last_name>Geetha Gopalakrishnan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center Clinical Trials Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212-3139</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>615-343-7146</phone>
    </contact>
    <investigator>
      <last_name>Andrea Utz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MidState Endocrine Associates</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>615-329-5029</phone>
    </contact>
    <investigator>
      <last_name>Terri Jerkins</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine Division of Endocrinology</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>713-873-8772</phone>
    </contact>
    <investigator>
      <last_name>Susan L. Samson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>City Creek Medical Specialists, Inc., Western Endocrine</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84103</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>801-408-5151</phone>
    </contact>
    <investigator>
      <last_name>James Grua</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Endocrinology Research</name>
      <address>
        <city>Chesapeake</city>
        <state>Virginia</state>
        <zip>23321</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>757-484-7822</phone>
    </contact>
    <investigator>
      <last_name>James LaRocque</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Cancer Institute Swedish Neuroscience Institute</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>206-386-2800</phone>
    </contact>
    <investigator>
      <last_name>Frances Broyles</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harborview Medical Center Neurological Surgery</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>206-744-9321</phone>
    </contact>
    <investigator>
      <last_name>Manuel Ferreira</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 7, 2014</lastchanged_date>
  <firstreceived_date>November 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acromegaly, Pituitary diseases</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acromegaly</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
